• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Active surveillance instead of immediate treatment may be appropriate for many men diagnosed with prostate cancer especially in the early stages10. GE Healthcare's technology can help monitor the patient and quickly identify any abnormal responses. It can also help characterise nodules or abnormalities with greater accuracy.

Products

MR_Product Listing Image_2020_320x180_3T_PETMR

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.
LOGIQ E10

LOGIQ™ E10 Ultrasound Series

Next-generation, leadership ultrasound that adapts to your needs, today and into the future.
OEC Elite CFD

OEC Elite CFD

The OEC Elite CFD offers stunning image clarity and detail at low dose with enhancements for an easy and efficient experience.

PET/CT

The true potential of PET/CT is its ability to enable a true discovery.
PETCT-banner-Mobile
References:
10. Cancer facts and figures 2018 [Internet]. Atlanta, Georgia: The American Cancer Society; 2018 [cited 2 November 2018]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf
JB04823XX